Showing 10 results

Filters Content type: Editors' picks Conference: EACS 2021
Mental & emotional health & wellbeing

HIV-specific mental health services across the EU

Editor's pick
i-Base
15 November 2021
Treatment simplification strategies

Implications of historical M184V on use of dual dolutegravir/lamivudine ART

Editor's pick
i-Base
15 November 2021
Cardiovascular disease

More Than Half of People Living With HIV Have Coronary Plaque

Editor's pick
Medscape (requires free registration)
8 November 2021
Coronavirus

People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV-2 infection

Editor's pick
NATAP
8 November 2021
Elimination of hepatitis C

How One Country Reduced HCV in MSM With HIV to Less Than 1%

Editor's pick
Medscape (requires free registration)
5 November 2021
Mental & emotional health problems

Stigma Drives Higher Depression Rate in HIV+ Men and Women in France

Editor's pick
NATAP
5 November 2021
Injectable & long-acting HIV treatment

Cabenuva Works Well Regardless of Body Weight

Editor's pick
POZ
5 November 2021
Retention & linkage to care

Less Viral Load Tracking During COVID Has No Immediate Ill Effects

Editor's pick
NATAP
31 October 2021
PrEP science

Kidney Toxicity Rare With Daily or On-Demand (As-Needed) PrEP

Editor's pick
NATAP
31 October 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces European Commission Decision for Vocabria (cabotegravir) and Rekambys (rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV

Editor's pick
ViiV Healthcare
28 October 2021